|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
| People with a visual impairment often experience problems in
differentiating packets, with the increased standardisation of
packaging sizes and shapes. They can also have problems with
reading the instructions since they are often printed in a small
typeface with poor visual quality. In order to alleviate these
problems, the European Commission has issued a directive requiring
suppliers of pharmaceutical products to incorporate braille labels
and produce information leaflets in alternative formats. However, the
associated standard has yet to be published, which leaves uncertainty
about the detailed implementation of the directive.
Packaging poses significant problems for many older people.
This is often due to an inability to read the label, understand its
meaning or open the package without damaging the contents.
Failure to take medicine correctly has been estimated to cost the
US economy $100 billion per year (1). THE VISUALLY IMPAIRED POPULATIONAbout 1.5 per cent of the population could be officially registered as
‘blind’ or ‘partially sighted’. Of these, around 0.4 per cent have to
rely on non-visual methods to access information (2)... |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
ELIX Polymers provides leading quality assurance and technical value services for pre-coloured ABS used in healthcare applications
Tarragona, January 21, 2020 – ELIX Polymers, a leading specialist
in high-performance ABS materials, will demonstrate its commitment in
the healthcare sector at Pharmapack 2020, the European pharma packaging
industry exhibition taking place on February 5 and 6 at Paris Expo,
Porte de Versailles. The company, which is enhancing the visibility of
its quality assurance and key technical services associated with
medical-grade pre-coloured ABS compounds, has its own stand, K60, in
Hall 7.2. It will show its product portfolio, demonstrate new
innovations, and discuss its service offering.
More info >> |
|
 |
White Papers |
 |
|
Key to Outsourcing Method Development and Validation: A Pragmatic Approach
RSSL
In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP).
Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Europe
18-21 October 2020, Barcelona, Spain
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >> |
|
|
.jpg)
